Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Cytokinetics (CYTK) Return on Assets (2016 - 2025)

Cytokinetics (CYTK) has disclosed Return on Assets for 14 consecutive years, with 0.27% as the latest value for Q4 2025.

  • On a quarterly basis, Return on Assets changed N/A to 0.27% in Q4 2025 year-over-year; TTM through Dec 2025 was 0.27%, a N/A change, with the full-year FY2023 number at 0.57%, down 20.0% from a year prior.
  • Return on Assets was 0.27% for Q4 2025 at Cytokinetics, down from 0.23% in the prior quarter.
  • In the past five years, Return on Assets ranged from a high of 0.22% in Q1 2021 to a low of 0.69% in Q3 2023.
  • A 5-year average of 0.38% and a median of 0.33% in 2022 define the central range for Return on Assets.
  • Peak YoY movement for Return on Assets: plummeted -43bps in 2023, then skyrocketed 31bps in 2024.
  • Cytokinetics' Return on Assets stood at 0.24% in 2021, then plummeted by -35bps to 0.33% in 2022, then tumbled by -104bps to 0.67% in 2023, then soared by 43bps to 0.38% in 2024, then grew by 28bps to 0.27% in 2025.
  • Per Business Quant, the three most recent readings for CYTK's Return on Assets are 0.27% (Q4 2025), 0.23% (Q3 2025), and 0.36% (Q2 2025).